110 computer-programmer-"https:"-"CEA-Saclay" "https:" "https:" "https:" "https:" "https:" "Dr" "UCL" positions at City of Hope
Sort by
Refine Your Search
-
Querfeld, M.D., Ph.D., director of the Cutaneous Lymphoma program, seeks better treatment options for cutaneous T cell lymphoma (CTCL), a rare form of lymphoma that first appears on the skin but can also
-
the Hematologic Malignancies Research Institute and the Childhood, Adolescent and Young Adult Survivorship Program . You will manage an assigned set of multiple research protocols to assure efficiency and
-
autonomy. You will work with Cherng Center leadership to grow the research program and its educational offerings. You will serve as a project manager, navigating the regulatory review process for each
-
through cutting-edge research. A Clinical Research Associate I role is available under Dr Ravi Salgia, a thoracic oncologist. You will support the clinical and translational research program by performing
-
medicine, vascular biology, bioengineering, and data science, Dr. Chen leads an active research program focused on epigenetics, RNA and chromatin biology and endothelial stress response. Her team integrates
-
within the translational hematopathology program led by Dr. M. James You. The successful candidate will develop a focused research program aligned with the laboratory's core themes, including leukemic stem
-
, shaping the future of medicine through cutting-edge research. A Clinical Research Assistant I role is available under Dr. Sumanta Pal within the Genitourinary group in the Department of Medical Oncology
-
, shaping the future of medicine through cutting-edge research. A Postdoctoral Fellow role is available in the lab of Dr. Annabel Wang. The research in her laboratory focuses on the metabolic and cellular
-
Querfeld, M.D., Ph.D., director of the Cutaneous Lymphoma program, seeks better treatment options for cutaneous T cell lymphoma (CTCL), a rare form of lymphoma that first appears on the skin but can also
-
genes related to the development of type 2 diabetes and cardiovascular disease in the Hispanic population. He also continues to oversee the Diabetes and Cardiovascular Risk Reduction Program, which he